Quadrature Capital Ltd Purchases 6,192 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Quadrature Capital Ltd boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 30.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,232 shares of the company’s stock after purchasing an additional 6,192 shares during the period. Quadrature Capital Ltd’s holdings in HCA Healthcare were worth $7,103,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Stone House Investment Management LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth about $25,000. Centerpoint Advisors LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at about $27,000. Atlantic Edge Private Wealth Management LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at about $27,000. Bruce G. Allen Investments LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at about $28,000. Finally, FinTrust Capital Advisors LLC lifted its stake in HCA Healthcare by 26.7% in the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after purchasing an additional 35 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research report on Thursday, May 30th. Barclays boosted their price objective on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a research note on Monday, April 29th. Finally, Oppenheimer upped their price target on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research report on Monday, April 29th. Four investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $325.59.

View Our Latest Report on HCA Healthcare

Insider Buying and Selling

In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the sale, the senior vice president now owns 22,365 shares in the company, valued at approximately $6,977,880. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 1,600 shares of the firm’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the sale, the executive vice president now owns 34,124 shares in the company, valued at approximately $10,544,316. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,273 shares of company stock valued at $4,211,228. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Trading Down 0.6 %

NYSE:HCA opened at $335.47 on Tuesday. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The firm has a market cap of $87.86 billion, a price-to-earnings ratio of 16.72, a price-to-earnings-growth ratio of 1.56 and a beta of 1.69. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $343.53. The firm has a 50-day moving average price of $320.93 and a two-hundred day moving average price of $313.36.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The company had revenue of $17.34 billion during the quarter, compared to analyst estimates of $16.81 billion. During the same quarter last year, the business posted $4.93 EPS. HCA Healthcare’s quarterly revenue was up 11.2% compared to the same quarter last year. On average, equities analysts expect that HCA Healthcare, Inc. will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.79%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.